日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Atezolizumab plus FOLFOX for Stage III Mismatch Repair-Deficient Colon Cancer

阿特珠单抗联合FOLFOX方案治疗III期错配修复缺陷型结肠癌

Sinicrope, Frank A; Ou, Fang-Shu; Arnold, Dirk; Peters, Walter R; Behrens, Robert J; Lieu, Christopher H; Matin, Khalid; Cohen, Deirdre J; Potter, Samara L; Nixon, Andrew B; Kottschade, Lisa A; Kathol, Emily; Frankel, Wendy L; Shergill, Ardaman; Hsu, Dennis; Reinacher-Schick, Anke; Mehan, Paul; Gold, Philip J; Khalil, Maged F; Zemla, Tyler; Gatten, Clare; O'Reilly, Eileen M; Meyerhardt, Jeffrey A

Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for stage III melanoma: outcomes and the impact of the microbiome from the NeoACTIVATE trial

新辅助治疗方案:cobimetinib 和 atezolizumab 联合或不联合 vemurafenib 治疗 III 期黑色素瘤:NeoACTIVATE 试验的结果及微生物组的影响

Block, Matthew S; Nelson, Garth D; Chen, Jun; Johnson, Stephen; Yang, Lu; Flotte, Thomas James; Grewal, Eric P; McWilliams, Robert R; Kottschade, Lisa A; Domingo-Musibay, Evidio; Markovic, Svetomir N; Dimou, Anastasios; Montane, Heather N; Piltin, Mara A; Price, Daniel L; Khariwala, Samir S; Hui, Jane Yuet Ching; Erskine, Courtney L; Strand, Carrie A; Zahrieh, David; Dong, Haidong; Hieken, Tina J

Clinical characteristics, outcomes, and predictive modeling of patients diagnosed with immune checkpoint inhibitor therapy-related pneumonitis

免疫检查点抑制剂治疗相关性肺炎患者的临床特征、预后及预测模型

Hazim, Antonious; Guiance, Irene Riestra; Shreve, Jacob; Ruan, Gordon; McGlothlin, Damian; LeMahieu, Allison; Haemmerle, Robert; Mcconn, Keith; Godby, Richard C; Kottschade, Lisa; Schwecke, Anna; Fazer-Posorske, Casey; Peikert, Tobias; Edell, Eric; Leventakos, Konstantinos; Egan, Ashley

Performance Comparison of Liquid Chromatography and Paper Spray Ionization with Mass Spectrometry for Measuring Kinase Inhibitors in Human Plasma

液相色谱-质谱联用和纸喷雾电离-质谱联用测定人血浆中激酶抑制剂的性能比较

Lahr, Richard G; Meyer, Makenzie; Nelson, Leah; Kottschade, Lisa A; Jannetto, Paul J; Yang, Yifei K

Impact of Social Determinants of Health on Melanoma Nodal Surveillance in a Multi-institutional Cohort

社会决定因素对多中心队列中黑色素瘤淋巴结监测的影响

Montgomery, Kelsey B; McLeod, M Chandler; DePalo, Danielle K; Dugan, Michelle M; Zager, Jonathan S; Elleson, Kelly M; Sabel, Michael S; Hieken, Tina J; Kottschade, Lisa A; Ollila, David W; Pham, Veronica; Archer, Dion; Berman, Russell S; Lee, Ann Y; Cintolo-Gonzalez, Jessica A; McDonald, Hannah G; Winchester, Sydney; Burke, Erin E; Rhodin, Kristen E; Beasley, Georgia M; Broman, Kristy K

Tumor-Infiltrating Lymphocyte Cell Therapy for the Treatment of Advanced Melanoma: From Patient Identification to Posttreatment Management

肿瘤浸润淋巴细胞疗法治疗晚期黑色素瘤:从患者筛选到治疗后管理

Kottschade, Lisa; Rodriguez, Emily Webb; Harding, Susan; Ranjan, Smita; Mcintyre, Lori; Prieto, Peter A; Gray, Lissa; Joseph, Jannakie; Swank, Jennifer

Symptom monitoring with electronic patient-reported outcomes during cancer treatment: final results of the PRO-TECT cluster-randomized trial

利用电子患者报告结局监测癌症治疗期间的症状:PRO-TECT 整群随机试验的最终结果

Basch, Ethan; Schrag, Deborah; Jansen, Jennifer; Henson, Sydney; Ginos, Brenda; Stover, Angela M; Carr, Philip; Spears, Patricia A; Jonsson, Mattias; Deal, Allison M; Bennett, Antonia V; Thanarajasingam, Gita; Rogak, Lauren; Reeve, Bryce B; Snyder, Claire; Bruner, Deborah; Cella, David; Kottschade, Lisa A; Perlmutter, Jane; Geoghegan, Cindy; Given, Barbara; Mazza, Gina L; Miller, Robert; Strasser, Jon F; Zylla, Dylan M; Weiss, Anna; Blinder, Victoria S; Wolf, Anna P; Dueck, Amylou C

Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial

新辅助治疗方案:cobimetinib 和 atezolizumab 联合或不联合 vemurafenib 用于高危可手术 III 期黑色素瘤:II 期 NeoACTIVATE 试验

Tina J Hieken ,Garth D Nelson ,Thomas J Flotte ,Eric P Grewal ,Jun Chen ,Robert R McWilliams ,Lisa A Kottschade ,Lu Yang ,Evidio Domingo-Musibay ,Roxana S Dronca ,Yiyi Yan ,Svetomir N Markovic ,Anastasios Dimou ,Heather N Montane ,Courtney L Erskine ,Mara A Piltin ,Daniel L Price ,Samir S Khariwala ,Jane Hui ,Carrie A Strand ,Susan M Harrington ,Vera J Suman ,Haidong Dong ,Matthew S Block

A Phase I Trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic Malignancies

针对妇科恶性肿瘤的白蛋白紫杉醇/贝伐单抗(AB160)纳米免疫偶联物治疗 I 期临床试验

Eleftheria Kalogera, Wendy K Nevala, Heidi D Finnes, Vera J Suman, Jill M Schimke, Carrie A Strand, Lisa A Kottschade, Rachel A Kudgus, Sarah A Buhrow, Laura R Becher, Liyi Geng, Gretchen E Glaser, Megan E Grudem, Aminah Jatoi, Carolyn M Klampe, Amanika Kumar, Carrie L Langstraat, Robert R McWilliam

Defining the Role of the Advanced Practice Provider Within the National Cancer Institute Community Oncology Research Program

明确高级实践提供者在国家癌症研究所社区肿瘤研究项目中的角色

Braun-Inglis, Christa M; Dressler, Emily V; Myers, Jamie S; Benson, Al B 3rd; Flannery, Marie; Good, Marjorie; Denicoff, Andrea; Berenberg, Jeffrey L; DeTroye, Alisha T; O'Brien, Bridget; Kottschade, Lisa; Omatsu, Dee Ann; Kittel, Carol A; Nightingale, Chandylen L; Foust, Melyssa; Lesser, Glenn J